Can Gefitinib be reimbursed by medical insurance?

Gefitinib is an oral drug that belongs to a class of drugs called tyrosine kinase inhibitors (TKIs) and is used to treat certain types of non-small cell lung cancer (NSCLC). It interferes with tumor growth and spread by inhibiting the activity of epidermal growth factor receptor (EGFR) tyrosine kinase in tumor cells.

Gefitinib was launched in China in 2005. At that time, the price of a box was about 5,000 yuan. Enter medical insurance in China in 2017. The price after medical insurance has dropped a lot. For the specific price after medical insurance, please consult the local hospital pharmacy or the medical insurance bureau. Other versions include original drugs and cost-effective generic drugs. Generic drugs include generic drugs from India, Bangladesh and Laos. The prices vary with different specifications, about 200~800yuan, and the ingredients of generic drugs are basically the same as domestic drugs.

Gefitinib is mainly used to treat advanced or metastatic non-small cell lung cancer with EGFR gene mutations. EGFRGene mutations are a common genetic abnormality that may cause lung cancer cells to overgrow and spread. This medication is usually used when other treatments are not effective or appropriate.

Gefitinib is available as an oral tablet. It is usually recommended to take the medicine at the dose and time prescribed by the doctor under the guidance of a doctor every day. The tablets can be taken before or after meals, and the specific time and dosage should be followed as recommended by your doctor.

Doses are often adjusted based on the patient's condition, including the type of genetic mutation, disease progression, and the patient's overall health. Doctors will use these factors to determine the right dosage for the patient.

Gefitinib can significantly improve the condition of some EGFR mutation-positive patients, but it may also be accompanied by some side effects, such as skin reactions, gastrointestinal discomfort, fatigue, etc. Doctors will inform patients in detail about possible side effects and how to deal with them before treatment begins.

xa0